focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXcite Energy Regulatory News (XEL)

  • There is currently no data for XEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re-financing of Unsecured Loan Notes

17 Dec 2013 07:00

RNS Number : 6905V
Xcite Energy Limited
17 December 2013
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

LSE-AIM, TSX-V: XEL

 

 

 

 

17 December 2013

 

 

Xcite Energy Limited

 

("Xcite Energy" or the "Company")

 

Re-financing of Unsecured Loan Notes

 

 

Xcite Energy has agreed to issue new 12.5% unsecured loan notes (the "Loan Notes") in the aggregate principal amount of US$80 million on a private placement basis, in order to repay its outstanding 14% unsecured loan notes, currently valued at approximately US$72 million aggregate principal amount (including payment-in-kind interest accrued), with the balance of proceeds to be used for general corporate purposes. The issuance of Loan Notes is expected to close on, or about, 30 December 2013. The Loan Notes will be purchased by several investors, including funds managed by West Face Capital Inc (the "Investors").

 

The Loan Notes will be issued at a 2% discount, have an initial term of 360 days and may be extended by the Company for an additional 360 days, subject to unanimous noteholder consent. The coupon of 12.5% on the Loan Notes is payable quarterly in arrears in cash.

 

The noteholders are entitled to a termination payment of 1% of the aggregate principal amount of the Loan Notes to be issued at closing, which is payable at the earlier of full repayment of the Loan Notes or the maturity date. In all other material respects, the terms of the Loan Notes remain consistent with the terms of the Company's existing 14% unsecured loan notes being repaid.

 

At closing, the Investors will also subscribe for a total of 1,000,000 units (consisting of one ordinary share in the capital of the Company (a "Share") and one ordinary share purchase warrant (a "Warrant"), together the "Units") on a private placement basis at a subscription price of £0.98 (equivalent to US$1.60) per Unit, (being the 10 day trailing volume weighted average price per Share on AIM), resulting in approximately £0.98 million (US$1.6 million) of additional proceeds payable to the Company (the "Private Placement"). Each Warrant will be exercisable for one additional Share at an exercise price of £0.98 per Share for a period of three years from the closing date.

 

Additional Information

 

The closing of the Private Placement is subject to final acceptance from the TSX-V. Except in accordance with Canadian securities laws, the Shares forming part of the Units and the Shares issuable upon exercise of the Warrants may not be sold or otherwise traded on or through the facilities of the TSX-V or otherwise in Canada or to or for the benefit of a Canadian resident until the date that is four months and one day from the date of issue.

 

Application will be made for admission to the AIM of the 1,000,000 Shares forming part of the Units ("Admission"), and dealings are expected to commence on 30 December 2013. The Shares will rank pari passu in all respects with the Company's existing issued ordinary shares of no par value.

 

Pareto Securities AS acted as Bookrunner to the Company with respect to the issuance of the Loan Notes and the Private Placement, and will be paid a fee of approximately $0.5 million.

 

Total Voting Rights

 

Following Admission, the Company's enlarged issued share capital will comprise 292,811,000 Shares with one voting right per Share. There are no Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 292,811,000. At Admission there will be a total of 17,250,000 outstanding warrants and 25,652,000 outstanding options to subscribe for Shares.

 

This figure of 292,811,000 Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

This press release shall not constitute an offer for sale of the securities referenced herein in the United States. The securities offered have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States absent registration or an exemption from those registration requirements.

 

 

ENQUIRIES:

 

Xcite Energy Limited

 

 

 

+44 (0) 1483 549 063

Rupert Cole / Andrew Fairclough

 

 

 

 

Liberum Capital Limited (Joint Broker and Nominated Adviser)

+44 (0) 203 100 2000

Clayton Bush / Tim Graham

 

 

 

 

Morgan Stanley (Joint Broker)

 

+44 (0) 207 425 8000

Andrew Foster

 

 

 

 

Pelham Bell Pottinger

 

+44 (0) 207 861 3232

Mark Antelme / Henry Lerwill

 

 

 

Paradox Public Relations

 

+1 514 341 0408

Jean-Francois Meilleur

 

 

 

 

 

 

Forward-Looking Statements

 

Certain statements contained in this announcement constitute forward-looking information within the meaning of securities laws. Forward-looking information may relate to the Company's future outlook and anticipated events or results and, in some cases, can be identified by terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "intend", "estimate", "predict", "target", "potential", "continue" or other similar expressions concerning matters that are not historical facts. These statements are based on certain factors and assumptions including expected growth, results of operations, performance and business prospects and opportunities. While the Company considers these assumptions to be reasonable based on information currently available to us, they may prove to be incorrect. Forward-looking information is also subject to certain factors, including risks and uncertainties that could cause actual results to differ materially from what we currently expect. These factors include risks associated with the oil and gas industry (including operational risks in exploration and development and uncertainties of estimates oil and gas potential properties), the risk of commodity price and foreign exchange rate fluctuations and the ability of Xcite Energy to secure financing. Additional information identifying risks and uncertainties are contained in the annual Management's Discussion and Analysis for Xcite Energy dated 25 March 2013 filed with the Canadian securities regulatory authorities and available at www.sedar.com. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDXBDDUBBBGXL
Date   Source Headline
22nd Nov 20164:00 pmRNSStatement re Court Hearing Date
2nd Nov 20167:00 amRNSStatement re Resignation of Director
28th Oct 20167:00 amRNSStatement re Resignation of Nominated Adviser
25th Oct 201612:45 pmRNSSuspension - Xcite Energy Limited
25th Oct 201612:45 pmRNSStatement re Shareholder Update
13th Oct 201611:15 amRNSStatement re Re-filing of Articles of Association
7th Oct 20164:40 pmRNSSecond Price Monitoring Extn
7th Oct 20164:35 pmRNSPrice Monitoring Extension
30th Sep 20163:30 pmRNSStatement re Result of Bondholder Meeting
29th Sep 20164:35 pmRNSPrice Monitoring Extension
27th Sep 20162:00 pmRNSStatement re Proposed Restructure
12th Sep 20167:00 amRNSStmnt re Share Price Movement
5th Sep 20164:40 pmRNSSecond Price Monitoring Extn
5th Sep 20164:35 pmRNSPrice Monitoring Extension
25th Aug 20164:40 pmRNSSecond Price Monitoring Extn
25th Aug 20164:35 pmRNSPrice Monitoring Extension
8th Aug 20164:40 pmRNSSecond Price Monitoring Extn
8th Aug 20164:35 pmRNSSecond Price Monitoring Extn
8th Aug 201612:07 pmRNSSecond Price Monitoring Extn
8th Aug 201612:02 pmRNSPrice Monitoring Extension
3rd Aug 20167:00 amRNSSecond Quarter Results
27th Jul 20163:35 pmRNSResults of Annual General and Special Meeting
4th Jul 20167:00 amRNSNotice of AGM
30th Jun 20169:16 amRNSResult of Bondholder Meeting
17th Jun 201612:47 pmRNSShareholder Update
16th Jun 20167:00 amRNSSummons to Bondholders' Meeting
24th May 20167:00 amRNSNotification of Director's circumstances
24th May 20167:00 amRNS1st Quarter Results
12th Apr 20164:40 pmRNSSecond Price Monitoring Extn
12th Apr 20164:35 pmRNSPrice Monitoring Extension
31st Mar 20167:00 amRNSCessation to be a Reporting Issuer and AGM
21st Mar 20167:00 amRNSFull Year Results
21st Mar 20167:00 amRNSReserves and Resources Assessment Report
7th Mar 20169:20 amRNSShare Price Movement
18th Feb 20167:26 amRNSBentley Licence Extension Update
23rd Dec 20157:00 amRNSApplication to cease to be reporting issuer Canada
23rd Nov 20157:00 amRNS3rd Quarter Results
11th Nov 20157:00 amRNSFarm-in Agreement with Azinor Catalyst
16th Sep 20157:00 amRNSVoluntary Delisting from TSX Venture Exchange
24th Aug 20157:00 amRNSHalf Yearly Report
29th May 20157:00 amRNS1st Quarter Results
14th May 20154:13 pmRNSResult of AGM
30th Apr 20157:00 amRNSFiling of Annual NI 51-101 Reserves Report
25th Mar 20157:00 amRNSResults for the Year Ended 31 December 2014
11th Mar 20153:01 pmRNSAdvance Notice of the Annual General Meeting
21st Nov 20147:00 amRNS3rd Quarter Results
17th Nov 20147:00 amRNSMemorandum of Understanding
21st Oct 20147:00 amRNSDirector Share Purchases
20th Oct 20147:00 amRNSMemorandum of Understanding with Baker Hughes
29th Sep 20147:00 amRNSExercise of Share Options & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.